Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Apabetalone

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit
    Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit

    22 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/22/2502072/0/en/Resverlogix-Publishes-New-Data-Highlighting-Apabetalone-s-Benefit-in-Non-alcoholic-Fatty-Liver-Disease.html

    GLOBENEWSWIRE
    22 Aug 2022
    Share Share
    Apabetalone's Positive Impact on PAH Published in the ARCCD
    Apabetalone's Positive Impact on PAH Published in the ARCCD

    17 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/17/2405113/0/en/Apabetalone-s-Positive-Impact-on-Pulmonary-Arterial-Hypertension-Published-in-the-American-Journal-of-Respiratory-and-Critical-Care-Medicine.html

    GLOBENEWSWIRE
    17 Mar 2022
    Share Share
    Resverlogix expands Phase IIb apabetalone trial for Covid-19
    Resverlogix expands Phase IIb apabetalone trial for Covid-19

    18 Feb 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/resverlogix-apabetalones-trial-covid-19/

    CLINICALTRIALSARENA
    18 Feb 2022
    Share Share
    Resverlogix Commences Patient Enrollment and Dosing in a Phase 2b Trial
    Resverlogix Commences Patient Enrollment and Dosing in a Phase 2b Trial

    18 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/18/2368307/0/en/Resverlogix-Announces-Commencement-of-Patient-Enrollment-and-Dosing-in-a-Phase-2b-Trial-for-a-Promising-Canadian-Developed-COVID-19-Treatment.html

    GLOBENEWSWIRE
    18 Jan 2022
    Share Share
    New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19
    New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19

    03 Mar 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/03/03/2186187/0/en/New-Published-Evidence-of-Apabetalone-s-Beneficial-Effects-on-COVID-19.html#:~:text=Publication%20Highlights%20include%3A&text=Apabetalone%20treatment%20was%20found%20to,virus'%20entry%20into%20human%20cells)

    GLOBENEWSWIRE
    03 Mar 2021
    Share Share
    Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
    Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure

    12 Jan 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/01/12/2157040/0/en/Apabetalone-s-Positive-Effect-on-Hospitalized-Patients-Involving-Heart-Failure.html

    GLOBENEWSWIRE
    12 Jan 2021
    Share Share